Vycor Medical (VYCO) Short-Term Debt issuances (2017 - 2023)
Vycor Medical (VYCO) reported Short-Term Debt issuances of $32879.0 for Q3 2023, down 7.64% year-over-year from $35600.0 in Q3 2022, and up 511.71% on a QoQ basis from -$7986.0 in Q2 2023.
Vycor Medical (VYCO) has 7 years of Short-Term Debt issuances data on file, last reported at $32879.0 in Q3 2023.
- Quarterly Short-Term Debt issuances fell 7.64% year-over-year to $32879.0 in Q3 2023, while the trailing twelve-month figure through Sep 2023 was -$13425.0 (down 1238.48% YoY) and the FY2022 annual result came in at -$6611.0, up 0.66% from the prior year.
- Short-Term Debt issuances rose to $32879.0 in Q3 2023 per VYCO's latest filing, from -$7986.0 in the prior quarter.
- Across five years, Short-Term Debt issuances topped out at $38727.0 in Q3 2021 and bottomed at -$25003.0 in Q4 2022.
- The 5-year median for Short-Term Debt issuances is -$8517.0 (2021), against an average of -$79.89.
- Peak annual rise in Short-Term Debt issuances reached 116.81% in 2021, while the deepest fall reached 192.66% in 2021.
- Tracing VYCO's Short-Term Debt issuances over 5 years: stood at -$23026.0 in 2019, then gained by 8.44% to -$21082.0 in 2020, then climbed by 8.0% to -$19395.0 in 2021, then fell by 28.91% to -$25003.0 in 2022, then jumped by 231.5% to $32879.0 in 2023.
- Per Business Quant, the three latest VYCO Short-Term Debt issuances figures stand at $32879.0 (Q3 2023), -$7986.0 (Q2 2023), and -$13315.0 (Q1 2023).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Short-Term Debt issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 31.00 Mn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -1.23 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -1.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 37.80 Mn |
| 10 | Vycor Medical | - | - | 375,153.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 32,879.00 |
| Sep 30, 2023 | 32,879.00 |
| Jun 30, 2023 | -7,986.00 |
| Jun 30, 2023 | -7,986.00 |
| Mar 31, 2023 | -13,315.00 |
| Mar 31, 2023 | -13,315.00 |
| Dec 31, 2022 | -25,003.00 |
| Dec 31, 2022 | -25,003.00 |
| Sep 30, 2022 | 35,600.00 |
| Sep 30, 2022 | 35,600.00 |
| Jun 30, 2022 | -5,617.00 |
| Jun 30, 2022 | -5,617.00 |
| Mar 31, 2022 | -11,591.00 |
| Mar 31, 2022 | -11,591.00 |
| Dec 31, 2021 | -19,395.00 |
| Dec 31, 2021 | -19,395.00 |
| Sep 30, 2021 | 38,727.00 |
| Sep 30, 2021 | 38,727.00 |
| Jun 30, 2021 | -8,517.00 |
| Jun 30, 2021 | -8,517.00 |
| Mar 31, 2021 | -17,470.00 |
| Mar 31, 2021 | -17,470.00 |
| Dec 31, 2020 | -21,082.00 |
| Dec 31, 2020 | -21,082.00 |
| Sep 30, 2020 | 17,862.00 |
| Sep 30, 2020 | 17,862.00 |
| Jun 30, 2020 | -17,681.00 |
| Jun 30, 2020 | -17,681.00 |
| Mar 31, 2020 | 18,853.00 |
| Mar 31, 2020 | 18,853.00 |
| Dec 31, 2019 | -23,026.00 |
| Dec 31, 2019 | -23,026.00 |
| Sep 30, 2019 | 25,490.00 |
| Sep 30, 2019 | 25,490.00 |
| Jun 30, 2019 | -22,075.00 |
| Jun 30, 2019 | -22,075.00 |
| Mar 31, 2019 | 21,829.00 |
| Mar 31, 2019 | 21,829.00 |
| Dec 31, 2018 | -21,052.00 |
| Dec 31, 2018 | -21,052.00 |
| Sep 30, 2018 | 23,786.00 |
| Sep 30, 2018 | 23,786.00 |
| Jun 30, 2018 | -20,479.00 |
| Jun 30, 2018 | -20,479.00 |
| Mar 31, 2018 | 25,166.00 |
| Mar 31, 2018 | 25,166.00 |
| Dec 31, 2017 | 66,575.00 |
| Dec 31, 2017 | 66,575.00 |
| Sep 30, 2017 | -27,303.00 |
| Sep 30, 2017 | -27,303.00 |
| Jun 30, 2017 | -14,350.00 |
| Jun 30, 2017 | -14,350.00 |
| Mar 31, 2017 | -23,385.00 |
| Mar 31, 2017 | -23,385.00 |